IRTC

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About iRhythm Technologies Inc

iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company believes improvements in arrhythmia detection and characterization have the potential to change clinical management of patients.
CEO
Kevin King
Employees
1157
Headquarters

650 Townsend St Ste 500
San Francisco, California 94103-6227
Phone: 14156325700
www.irhythmtech.com

News

iRhythm Technologies (IRTC) Investor Presentation - Slideshow
Aug 17, 2022 17:24pm

The following slide deck was published by iRhythm Technologies, Inc.


Source:Seeking Alpha
iRhythm Technologies, Inc. (IRTC) CEO Quentin Blackford on Q2 2022 Results - Earnings Call Transcript
Aug 06, 2022 23:32pm

iRhythm Technologies, Inc. (NASDAQ:NASDAQ:IRTC) Q2 2022 Results Conference Call August 04, 2022 04:30 PM ET Company Participants Stephanie Zhadkevich - Director of Investor Relations…


Source:Seeking Alpha
iRhythm Technologies, Inc. Common Stock (IRTC) Q2 2022 Earnings Call Transcript
Aug 06, 2022 09:00am

IRTC earnings call for the period ending June 30, 2022.


Source:The Motley Fool
iRhythm Technologies PT Raised to $185 at Truist Securities
Aug 05, 2022 10:14am

https://www.investing.com/news/pro/irhythm-technologies-pt-raised-to-185-at-truist-securities-432SI-2864842


Source:Investing.com
iRhythm Technologies PT Raised to $178 at BTIG
Aug 05, 2022 10:01am

https://www.investing.com/news/pro/irhythm-technologies-pt-raised-to-178-at-btig-432SI-2864810


Source:Investing.com
iRhythm Technologies: Q2 Earnings Insights
Aug 04, 2022 21:40pm

iRhythm Technologies (NASDAQ: IRTC ) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:05 PM. Here''s what investors need to know about the announcement. Earnings iRhythm Technologies beat estimated earnings by 14.13%, reporting an EPS of $-0.79 versus an … Full story available on Benzinga.com


Source:Benzinga
iRhythm Technologies Q2 results beat estimates, co raises FY 2022 revenue guidance
Aug 04, 2022 20:12pm

iRhythm Technologies press release (IRTC): Q2 Non-GAAP EPS of -$0.79 beats by $0.11.Revenue of $102.1M (+25.6% Y/Y) beats by $1.59M.Raised full year 2022 revenue guidance to range…


Source:Seeking Alpha
iRhythm Technologies Announces Second Quarter 2022 Financial Results
Aug 04, 2022 20:05pm

SAN FRANCISCO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended June 30, 2022.


Source:GlobeNewswire
iRhythm Technologies to Present at the Canaccord Genuity 42nd Annual Growth Conference
Jul 28, 2022 20:30pm

SAN FRANCISCO, July 28, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced the company will be participating in the upcoming Canaccord Genuity 42nd Annual Growth Stock Conference.


Source:GlobeNewswire
iRhythm Technologies Reaches Analyst Target Price
Jul 28, 2022 13:34pm

In recent trading, shares of iRhythm Technologies Inc (Symbol: IRTC) have crossed above the average analyst 12-month target price of $152.78, changing hands for $153.59/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgr


Source:Nasdaq
iRhythm Technologies provides FY22 prelims, commercial chief resigns
Jul 19, 2022 10:29am

iRhythm Technologies (IRTC) announced that Dave Vort, Chief Commercial Officer, has resigned effective July 25, 2022; he will continue to serve as a strategic advisor and actively…


Source:Seeking Alpha
iRhythm Technologies Announces Chief Commercial Officer Transition and Schedules Second Quarter Earnings Release and Conference Call for August 4, 2022
Jul 18, 2022 20:10pm

SAN FRANCISCO, July 18, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that Dave Vort, the Company’s Chief Commercial Officer, has resigned effective July 25, 2022. To support continued growth and ongoing implementation of iRhythm’s commercial strategy, Mr. Vort will continue to serve the Company as a strategic advisor and actively engage with the Company’s leadership team through March 31, 2023.


Source:GlobeNewswire
Tesla, Twitter And 76 Biggest Movers From Friday
Jul 11, 2022 11:30am

Gainers Seritage Growth Properties (NYSE: SRG ) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board recommended shareholders to approve a proposed plan sale. Aditxt, Inc. (NASDAQ: ADTX ) shares climbed 50% to close at $0.24 on Friday after the company''s Adimune therapeutic program completed a toxicology study indicating a favorable safety profile of ADI-100. Waitr Holdings Inc. (NASDAQ: WTRH ) gained 48.5% to settle at $0.35 after the company announced a new partnership with Burq to allow deliveries from several new retail industries. Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) surged 44.4% to close at $8.20. MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD ) jumped 42.1% to close at $4.25 after gaining 9% on Thursday. Kura Sushi USA, Inc. (NASDAQ: KRUS ) climbed 33.6% to close at $72.29 after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY22 sales guidance above analyst estimates.


Source:Benzinga
IRTC stock nears 6-month high as analysts cheer Medicare proposed rule (NASDAQ:IRTC)
Jul 08, 2022 17:41pm

iRhythm Technologies (IRTC) recorded the second biggest intraday gain for the year on Friday to reach the highest level since January on the release of proposed Medicare reimbursement…


Source:Seeking Alpha
Why U.S. Stocks Are Trading Lower Despite Upbeat Nonfarm Payrolls Report
Jul 08, 2022 14:20pm

U.S. stocks traded lower this morning following the release of jobs report for the month of June. Following the market opening Friday, the Dow traded down 0.40% to 31,259.22 while the NASDAQ fell 0.92% to 11,514.48. The S&P also fell, dropping, 0.65% to 3,877.42. Also check this: GameStop, Levi Strauss And 3 Stocks To Watch Heading Into Friday Leading and Lagging Sectors Health care shares rose by 0.4% on Friday. Meanwhile, top gainers in the sector included MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD ), up 20% and iRhythm Technologies, Inc. (NASDAQ: IRTC ) up 22%. In trading on Friday, materials shares dipped by 1.2%. Top Headline The US economy added 372,000 payrolls in June, following a revised 384,000 growth in May. Analysts, however, were expecting for a 268,000 gain in jobs. Average hourly earnings for all employees on private nonfarm payrolls increased 0.3% to $32.08 in June. The US unemployment rate came in unchanged at 3.6% in June. Equities Trading UP Seritage Growth Properties (NYSE: SRG ) shares shot up 52% to $9.24 after the company appointed Adam Metz as Chairman.


Source:Benzinga
iRhythm jumps 11% after comments on proposed 2023 Medicare rates
Jul 08, 2022 13:06pm

iRhythm Technologies (IRTC), a maker of electrocardiogram ((ECG)) monitoring products added ~11% in the pre-market Friday after the company issued its comments on the Medicare…


Source:Seeking Alpha
iRhythm Technologies Comments on the Proposed Medicare Physician Fee Schedule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023
Jul 08, 2022 12:30pm

SAN FRANCISCO, July 08, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today provided comment on the recently released Centers for Medicare and Medicaid Services (“CMS”) Medicare Physician Fee Schedule Proposed Rule for Calendar Year 2023 (the “Proposed Rule”). The Proposed Rule


Source:Wallstreet:Online